NK-CELL LYMPHOMA: EXPLORING MARKET GROWTH AND DRUG INNOVATIONS

Natural Killer (NK)-cell lymphoma is a rare and aggressive cancer that originates in NK cells, a key component of the immune system responsible for eliminating infected or cancerous cells. Among its subtypes, extranodal NK/T-cell lymphoma, nasal type, is the most common. Due to the disease’s aggressive nature, treatment options remain limited, ma